Celldex Therapeutics
CLDX
#4902
Rank
NZ$3.05 B
Marketcap
NZ$46.00
Share price
-0.34%
Change (1 day)
1.68%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -NZ$0.45 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are NZ$2.6 Million. In 2024 the company made an earning of -NZ$0.34 Billion a decrease over its 2023 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.45 Billion30.93%
2024 -NZ$0.34 Billion37.34%
2023 -NZ$0.25 Billion32.63%
2022 -NZ$0.19 Billion54.88%
2021 -NZ$0.12 Billion39.49%
2020 -NZ$85.76 Million-9.08%
2019 -NZ$94.32 Million-28.64%
2018 -NZ$0.14 Billion-30.11%
2017 -NZ$0.19 Billion-17.75%
2016 -NZ$0.23 Billion4.5%
2015 -NZ$0.23 Billion4.09%
2014 -NZ$0.22 Billion51.57%
2013 -NZ$0.14 Billion40.1%
2012 -NZ$99.55 Million
2010 -NZ$2.16 Million-96.59%
2009 -NZ$63.32 Million
2006 -NZ$38.7 Million
2004 -NZ$23.5 Million15.75%
2003 -NZ$20.3 Million-18.69%
2002 -NZ$24.97 Million-41.22%
2001 -NZ$42.47 Million59%
2000 -NZ$26.71 Million27.65%
1999 -NZ$20.93 Million53.12%
1998 -NZ$13.67 Million2.6%
1997 -NZ$13.32 Million-33.62%
1996 -NZ$20.07 Million-1.69%
1995 -NZ$20.42 Million22.92%
1994 -NZ$16.61 Million-0%
1993 -NZ$16.61 Million
1991 -NZ$10.21 Million90.32%
1990 -NZ$5.37 Million10.71%
1989 -NZ$4.85 Million833.33%
1988 -NZ$0.52 Million-400%
1987 NZ$0.17 M-125%
1986 -NZ$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-NZ$1.37 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.74 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.26 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.50 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.12 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-NZ$4.86 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA